Literature DB >> 15811010

HJV gene mutations in European patients with juvenile hemochromatosis.

S G Gehrke1, A Pietrangelo, M Kascák, A Braner, M Eisold, H Kulaksiz, T Herrmann, U Hebling, K Bents, R Gugler, W Stremmel.   

Abstract

A large variety of mutations within the genes encoding hepcidin (HAMP) and hemojuvelin (HJV) have been identified in patients with the severe iron overload disorder juvenile hemochromatosis (JH). The aim of the present study was to evaluate the molecular background of JH in patients from central parts of Europe. Sequence analyses of HAMP and HJV were performed in seven JH patients from six families from Germany, Slovakia, and Croatia. For detection of the G320V mutation in HJV, a rapid polymerase chain reaction-based assay was developed. No mutations were found within the HAMP gene. Six of seven (86%) JH patients carried at least one copy of the G320V mutation within the HJV gene. Four of these patients were homozygous for the G320V mutation. In addition, two novel HJV mutations were identified (C119F and S328fsX337). Taken together, the present study demonstrates that molecular analysis of the HJV gene is a powerful tool for an early and reliable diagnosis of JH. As in affected patients from Greece, the G320V mutation seems to be widely distributed among JH patients from central parts of Europe. Therefore, detection of the G320V mutation could identify the majority of JH cases from these regions non-invasively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811010     DOI: 10.1111/j.1399-0004.2005.00413.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  16 in total

Review 1.  Hereditary hemochromatosis and transferrin receptor 2.

Authors:  Juxing Chen; Caroline A Enns
Journal:  Biochim Biophys Acta       Date:  2011-08-16

2.  Conserved proximal promoter elements control repulsive guidance molecule c/hemojuvelin (Hfe2) gene transcription in skeletal muscle.

Authors:  Christopher J Severyn; Peter Rotwein
Journal:  Genomics       Date:  2010-09-19       Impact factor: 5.736

3.  Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice.

Authors:  Andrea U Steinbicker; Thomas B Bartnikas; Lisa K Lohmeyer; Patricio Leyton; Claire Mayeur; Sonya M Kao; Alexandra E Pappas; Randall T Peterson; Donald B Bloch; Paul B Yu; Mark D Fleming; Kenneth D Bloch
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

4.  Two middle-age-onset hemochromatosis patients with heterozygous mutations in the hemojuvelin gene in a Chinese family.

Authors:  Shufeng Li; Jun Xue; Baojun Chen; Qiwei Wang; Minke Shi; Xiaojing Xie; Liang Zhang
Journal:  Int J Hematol       Date:  2014-03-02       Impact factor: 2.490

5.  Non-HFE hemochromatosis.

Authors:  Paulo Caleb Júnior de Lima Santos; Carla Luana Dinardo; Rodolfo Delfini Cançado; Isolmar Tadeu Schettert; José Eduardo Krieger; Alexandre Costa Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2012

6.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

Review 7.  Liver iron transport.

Authors:  Ross-M Graham; Anita-C-G Chua; Carly-E Herbison; John-K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 8.  Non-HFE haemochromatosis.

Authors:  Daniel-F Wallace; V-Nathan Subramaniam
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 9.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

10.  A late presentation of a fatal disease: juvenile hemochromatosis.

Authors:  Cynthia Cherfane; Pauline Lee; Leana Guerin; Kyle Brown
Journal:  Case Rep Med       Date:  2013-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.